298 related articles for article (PubMed ID: 8952463)
1. In vivo reconstitution of dopamine D2S receptor-mediated G protein activation in baculovirus-infected insect cells: preferred coupling to Gi1 versus Gi2.
Grünewald S; Reiländer H; Michel H
Biochemistry; 1996 Dec; 35(48):15162-73. PubMed ID: 8952463
[TBL] [Abstract][Full Text] [Related]
2. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
3. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.
Boundy VA; Lu L; Molinoff PB
J Pharmacol Exp Ther; 1996 Feb; 276(2):784-94. PubMed ID: 8632351
[TBL] [Abstract][Full Text] [Related]
4. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
5. Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
Tian WN; Duzic E; Lanier SM; Deth RC
Mol Pharmacol; 1994 Mar; 45(3):524-31. PubMed ID: 8145737
[TBL] [Abstract][Full Text] [Related]
6. The influence of G protein subtype on agonist action at D2 dopamine receptors.
Nickolls SA; Strange PG
Neuropharmacology; 2004 Nov; 47(6):860-72. PubMed ID: 15527820
[TBL] [Abstract][Full Text] [Related]
7. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
10. Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3.
Lane JR; Powney B; Wise A; Rees S; Milligan G
Mol Pharmacol; 2007 May; 71(5):1349-59. PubMed ID: 17287401
[TBL] [Abstract][Full Text] [Related]
11. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
Remmers AE; Clark MJ; Liu XY; Medzihradsky F
J Pharmacol Exp Ther; 1998 Nov; 287(2):625-32. PubMed ID: 9808689
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
Reyes-Cruz G; Vázquez-Prado J; Müller-Esterl W; Vaca L
J Cell Biochem; 2000 Jan; 76(4):658-73. PubMed ID: 10653985
[TBL] [Abstract][Full Text] [Related]
13. Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.
Gazi L; Nickolls SA; Strange PG
Br J Pharmacol; 2003 Mar; 138(5):775-86. PubMed ID: 12642378
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.
Brys R; Josson K; Castelli MP; Jurzak M; Lijnen P; Gommeren W; Leysen JE
Mol Pharmacol; 2000 Jun; 57(6):1132-41. PubMed ID: 10825383
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inverse agonist action at D2 dopamine receptors.
Roberts DJ; Strange PG
Br J Pharmacol; 2005 May; 145(1):34-42. PubMed ID: 15735658
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
Wise A; Sheehan M; Rees S; Lee M; Milligan G
Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
[TBL] [Abstract][Full Text] [Related]
17. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
18. Expression of human M2 muscarinic receptors in Sf9 cells: characterisation and reconstitution with G-proteins.
Heitz F; McClue SJ; Harris BA; Guenet C
J Recept Signal Transduct Res; 1995; 15(1-4):55-70. PubMed ID: 8903931
[TBL] [Abstract][Full Text] [Related]
19. Subtype-specific antibodies for muscarinic cholinergic receptors. II. Studies with reconstituted chick heart receptors and the GTP-binding protein G(o).
Richardson RM; Mayanil CS; Hosey MM
Mol Pharmacol; 1991 Dec; 40(6):908-14. PubMed ID: 1758442
[TBL] [Abstract][Full Text] [Related]
20. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
Boundy VA; Pacheco MA; Guan W; Molinoff PB
Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
